Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  BioPorto A/S    BIOPOR   DK0011048619

BIOPORTO A/S (BIOPOR)

 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
01/16/2017 01/17/2017 01/18/2017 01/19/2017 01/20/2017 Date
2.14(c) 2.11(c) 2.1(c) 2.14(c) 2.11 Last
61 440 229 851 190 192 53 460 31 363 Volume
-0.93% -1.40% -0.47% +1.90% -1.40% Change
More quotes
Company
BioPorto A/S is an in-vitro diagnostics company.It provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies.The company focuses on the diagnosis of obesity, diabetes, primary immune deficiency, and kidney injury.Its products include The NGAL... 
Sector
Pharmaceuticals
Calendar
03/15Earnings Release
More about the company
Latest news on BIOPORTO A/S
2016 BIOPORTO A/S : expands its NGAL related patent portfolio
2016 BIOPORTO A/S : BioPortos gRAD platform validated for QIAGENs ESEQuant lateral fl..
2016 BIOPORTO A/S : gRAD platform validated for QIAGEN’s ESEQuant lateral flow ..
2016 BIOPORTO A/S : Financial Calendar 2017
2016 BIOPORTO A/S : Share Capital and Votes
2016 BIOPORTO A/S : Completion of rights issue and capital increase
2016 BIOPORTO A/S : Completion of rights issue and capital increase
2016 BIOPORTO A/S : Managers’ transactions
2016 BIOPORTO A/S : completes cash issue, private placement
2016 BIOPORTO A/S : increases the share capital through a cash issue, private placeme..
More news
Sector news : Diagnostic & Testing Substances Manufacturers
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/19 GSK grabs Astra executive to replace pharma head
01/19DJGLAXOSMITHKLINE : Global Pharmaceuticals President Abbas Hussain to Leave -- Upd..
More sector news : Diagnostic & Testing Substances Manufacturers
Latest Tweets
2016BioPorto A/S: BioPorto expands its NGAL related patent portfolio #Finanzierun.. 
2016Nasdaq Copenhagen A/S: BioPorto A/S - admittance to trading and official list.. 
2016BioPorto A/S: The FDA rejects application for the registration og The NGAL Te.. 
More tweets
Qtime:15
Advertisement
Chart BIOPORTO A/S
Duration : Period :
BioPorto A/S Technical Analysis Chart | BIOPOR | DK0011048619 | 4-Traders
Full-screen chart
Technical analysis trends BIOPORTO A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Managers
NameTitle
Peter Mørch Eriksen CEO & Investor Relations Contact
Thomas Magnussen Chairman
Jan Kuhlmann Andersen Chief Operating Officer
Jakob Brix Christensen Chief Financial Officer
Torben A. Nielsen Vice Chairman
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOPORTO A/S0.00%0
JOHNSON & JOHNSON-0.88%310 685
ROCHE HOLDING LTD.1.29%200 208
PFIZER INC.-2.40%192 367
NOVARTIS AG-3.71%185 489
MERCK & CO., INC.2.48%166 338
More Results